Outpatient Parenteral Antibiotic Therapy in the Metropolitan Area of Cologne
NCT04002453 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2022-09-08
Summary
Many infectious diseases require a therapy that is administered intravenously due to a lack of oral treatments. Affected patients often have to stay weeks or even months in hospital just for receiving their therapy although they do not feel severely unwell.
Outpatient parenteral antibiotic therapy (OPAT) allows these patients under certain requirements to get discharged from hospital and apply the antibiotic treatment on their own. For these patients quality of life improves by feeling more comfortable at home and being able to participate in everyday life or even go back to work. For the hospitals a reduced inpatient health care means a clear reduction of costs.
The benefits of OPAT are obvious, shown by several studies, and in many countries e.g. the USA OPAT is a very well established way of treatment. In Germany however OPAT is used very infrequently and not in a standardized manner. This is probably due to inadequate knowledge of this form of treatment and deficits in the outpatient care structure, as OPAT is not reflected in the remuneration system of the German health care system despite internationally proven benefits.
The aim of this study is to identify and analyze possible obstacles to the implementation of OPAT into the standard patient care in Germany regarding financial, structural and medical limitations. Therefore the investigators intend to treat 120 patients in the metropolitan area of Cologne with OPAT and observe effectiveness, safety, logistics and acceptance to this kind of therapy.
If successful, the project should help to identify the potential of OPAT for Germany. If positive effects and feasibility can be demonstrated in the Cologne metropolitan region, OPAT could become an important therapy option with many advantages for certain patients.
Conditions
- Implementation of OPAT in Germany
Interventions
- PROCEDURE
-
Outpatient Parenteral Antibiotic Therapy
Application of outpatient parenteral antibiotic therapy in patients with infectious diseases to allow them to get discharged from hospital.
Sponsors & Collaborators
-
University of Cologne
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2022-12-31
- Completion
- 2023-06-30
Countries
- Germany
Study Locations
More Related Trials
-
Prophylactic Antibiotics on Urethral Catheter Withdrawal
NCT00126698 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Dosing in Pediatric Intensive Care
NCT02456974 ·Status: RECRUITING
-
Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy
NCT00214331 ·Status: COMPLETED
-
Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.
NCT07247942 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients
NCT03738683 ·Status: COMPLETED
-
Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)
NCT05156437 ·Status: TERMINATED ·Phase: PHASE4
-
Antibiotic Dosing in Geriatric Patients At the Emergency Department
NCT04436991 ·Status: RECRUITING
-
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
NCT06426836 ·Status: RECRUITING ·Phase: NA
-
Population Pharmacokinetics of Antibiotics in Critically Ill Children (POPSICLE)
NCT03248349 ·Status: UNKNOWN
-
S. Aureus Decolonization in HPN Patients.
NCT03173053 ·Status: TERMINATED ·Phase: NA
-
Antibiotic Prophylaxis for PEG in Children
NCT01870167 ·Status: UNKNOWN ·Phase: PHASE4
-
Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
NCT06929702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance
NCT04771884 ·Status: RECRUITING
-
Pharmacokinetics of Piperacillin and Meropenem in ICU Patients
NCT05134298 ·Status: UNKNOWN
-
Population Pharmacokinetics of Anti-infectives in Hospitalized Patients
NCT02998411 ·Status: RECRUITING
-
Flucloxacillin as an Inducer of CYP-enzymes
NCT04840641 ·Status: COMPLETED ·Phase: PHASE1
-
Fosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951 ·Status: RECRUITING
-
Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study
NCT01212432 ·Status: UNKNOWN ·Phase: PHASE2
-
Partial Oral Antibiotic Treatment for Bacterial Brain Abscess
NCT04140903 ·Status: RECRUITING ·Phase: PHASE4
-
Meropenem and Piperacillin Plasma Concentrations During CRRT
NCT04203784 ·Status: COMPLETED
-
Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
NCT01173575 ·Status: COMPLETED
-
Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients
NCT02993575 ·Status: COMPLETED
-
Prospective Randomized Evaluation of Antibiotic Regimen Following Appendectomy for Perforated Appendicitis
NCT00195923 ·Status: COMPLETED
-
Antibiotic Irrigations for Intra-Abdominal Drains
NCT03476941 ·Status: RECRUITING ·Phase: PHASE2
-
The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring
NCT03790631 ·Status: COMPLETED